Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myeloid Leukemia, Relapsed”

1,471 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,471 results

Testing effectiveness (Phase 2)UnknownNCT03356080
What this trial is testing

DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Shanghai Tong Ren Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00003255
What this trial is testing

Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 38
Early research (Phase 1)Ended earlyNCT03217838
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.

Who this might be right for
Acute Myeloid Leukaemia
AstraZeneca 50
Testing effectiveness (Phase 2)Study completedNCT02642965
What this trial is testing

Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Post Cytotoxic TherapyRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia
Children's Oncology Group 38
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Early research (Phase 1)Study completedNCT01174888
What this trial is testing

Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia FollowingMyelodysplastic Syndrome+8 more
Alison Walker 34
Early research (Phase 1)UnknownNCT04014881
What this trial is testing

Safety and Efficacy of Anti-CD123 CAR-T Therapy in Patients With Refractory/ Relapsed CD123+ Acute Myeloid Leukemia.

Who this might be right for
CD123+ Acute Myeloid Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Early research (Phase 1)Looking for participantsNCT06146257
What this trial is testing

GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
GluBio Therapeutics Inc. 48
Early research (Phase 1)Study completedNCT01120457
What this trial is testing

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Who this might be right for
Acute Myelogenous LeukemiaDiffuse Large B-Cell LeukemiaChronic Lymphocytic Leukemia+1 more
Bristol-Myers Squibb 96
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Early research (Phase 1)Study completedNCT01321346
What this trial is testing

Panobinostat In Children With Refractory Hematologic Malignancies

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more
Therapeutic Advances in Childhood Leukemia Consortium 30
Testing effectiveness (Phase 2)Study completedNCT00005795
What this trial is testing

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Northwestern University 11
Testing effectiveness (Phase 2)Study completedNCT00037596
What this trial is testing

Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Study completedNCT02270788
What this trial is testing

Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia
St. Jude Children's Research Hospital 10
Testing effectiveness (Phase 2)WithdrawnNCT01835288
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Stanford University
Early research (Phase 1)Study completedNCT00382954
What this trial is testing

Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML

Who this might be right for
Acute Myelogenous Leukemia
University of Kentucky 55
Testing effectiveness (Phase 2)Study completedNCT00512083
What this trial is testing

Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid
Antisoma Research 70
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07486726
What this trial is testing

Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)Relapse Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia (AML)
Shanghai Jiao Tong University School of Medicine 112
Post-approval studies (Phase 4)Study completedNCT03727750
What this trial is testing

Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML

Who this might be right for
ECGPharmacokineticsSafety
Pfizer 51
Load More Results